US Group Raises Pricing Recommendation For Gilead's Remdesivir In COVID.

US Group Raises Pricing Recommendation For Gilead's Remdesivir In COVID

A Gilead Sciences, Inc logo is seen outside company headquarters in Foster City, California (Reuters)

Gilead Sciences Inc's <GILD.O> antiviral remdesivir could be priced up to $5,080 per course based on benefits shown in COVID-19 patients, a U.S. drug pricing research group suggested on Wednesday, above its prior recommendation of around $4,500.

The Institute for Clinical and Economic Review (ICER) said its recommendation change stemmed from recent clinical data, updated cost estimates, public comments and interactions with Gilead.

However, Boston-based ICER suggested a lower price range of around $2,520 to $2,800, if steroid dexamethasone were to be cleared for use in COVID-19. The cheap and widely used steroid was found to reduce death rates in severely ill patients in a study earlier this month.

What Gilead could charge for remdesivir in the United States after its pledged donations are used up has been a topic of intense debate, with experts suggesting that Gilead would need to avoid the appearance of taking advantage of a health crisis for profits.

Remdesivir reduced hospital stays by 31%, compared to a placebo, in a clinical trial released in late April.

Gilead said it was reviewing the full report by ICER to understand what factors were considered.

"Post-donation, we are committed to making remdesivir both accessible and affordable to governments and patients around the world," a Gilead spokesman said in an email.

Wall Street analysts say the drug could generate billions of dollars in revenue over the next couple of years, assuming the pandemic continues.

Earlier this week, Gilead said it expects to be able to supply enough remdesivir by year-end to treat more than 2 million COVID-19 patients.

The drugmaker has signed licensing agreements with a bevy of Indian drugmakers including Cipla Ltd <CIPL.NS> and Hetero Labs Ltd.

Cipla's version is priced at 5,000 Indian rupees ($66.09), while Hetero Lab's version is priced at 5,400 rupees.

($1 = 75.6500 Indian rupees)

(Reporting by Saumya Sibi Joseph and Manas Mishra in Bengaluru; Editing by Shinjini Ganguli and Maju Samuel)

(This story has not been edited by NDTV staff and is auto-generated from a syndicated feed.)

Comments

Related news

Seoul mayor found dead left note saying ‘sorry to all people,’ no mention of allegations.

A mourning station was set up at a hospital to receive mourners for five days for Mayor Park Won-soon, once considered a presidential candidate.

Hong Kong police arrest 7 for ‘assisting’ suspect in stabbing officer at protest.

On July 2, police arrested a 24-year-old man at the airport on suspicion of stabbing an officer during the protest just hours after China's new security law was imposed.

Brazil President Says He's Taking Hydroxycholoroquine To Fight COVID-19.

Brazilian President Jair Bolsonaro, who has tested positive for COVID-19, said on Facebook Thursday that he was "very well" and again advocated the use of the controversial drug hydroxychloroquine.

1 8

Trump Says He'll Wear Mask During Upcoming Visit To Military Hospital.

US President Donald Trump, who has avoided being seen wearing a face covering in public, said on Thursday he expects to wear a mask when he next visits US troops at the Walter Reed National Military...

1 3

Coronavirus: Serbia withdraws weekend lockdown after massive protests.

A government crisis group decided instead on a more limited ban on outdoor and indoor public gatherings of more than 10 people. It also shortened working hours at indoor restaurants and cafes.

1 31

By continuing to browse World News (UAZMI), you acknowledge that you have read the Terms of Use and agree to the use of cookies